| 10947560 |
Modified serotype 28 adenoviral vectors |
Lisa Wei, Douglas E. Brough |
2021-03-16 |
|
| 10640776 |
Method for propagating adenoviral vectors encoding inhibitory gene products |
Jason G. D. Gall, Douglas E. Brough |
2020-05-05 |
|
| 9790519 |
Modified serotype 28 adenoviral vectors |
Lisa Wei, Douglas E. Brough |
2017-10-17 |
|
| 9738688 |
HIV-1 envelope glycoprotein |
Michael Caulfield, Albert Cupo, Hansi DEAN, Simon Hoffenberg, P. J. Klasse +6 more |
2017-08-22 |
|
| 9651543 |
Malaria antigen screening method |
Joseph T. Bruder, Imre Kovesdi, Duncan McVey, Douglas E. Brough, Denise Louise Doolan +5 more |
2017-05-16 |
|
| 9402894 |
Viral particles derived from an enveloped virus |
Michael Caulfield, Ivo Lorenz, Christopher L. Parks |
2016-08-02 |
|
| 9388429 |
Method for propagating adenoviral vectors encoding inhibitory gene products |
Jason G. D. Gall, Douglas E. Brough |
2016-07-12 |
$387,000 |
| 9254316 |
Adenoviral vector-based malaria vaccines |
Joseph T. Bruder, Thomas Richie, Keith Limbach, Denise Louise Doolan |
2016-02-09 |
|
| 8765146 |
Adenoviral vector-based malaria vaccines |
Joseph T. Bruder, Imre Kovesdi, Duncan McVey, Damodar Ettyreddy, Denise Louise Doolan +1 more |
2014-07-01 |
$1,607,000 |
| 8454972 |
Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen |
Gary J. Nabel, Yue Huang, Ling Xu, Bimal Chakrabarti, Lan Wu +2 more |
2013-06-04 |
$102,000 |
| 8450055 |
Malaria antigen screening method |
Joseph T. Bruder, Imre Kovesdi, Duncan McVey, Douglas E. Brough, Denise Louise Doolan +5 more |
2013-05-28 |
|
| 8323961 |
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV |
Gary J. Nabel, Bimal Chakrabarti, Wing-Pui Kong, Yue Huang, Zhi-yong Yang +1 more |
2012-12-04 |
|
| 8323663 |
Adenoviral vector-based foot-and-mouth disease vaccine |
Douglas E. Brough, Joseph T. Bruder, Marvin J. Grubman, John Neilan |
2012-12-04 |
$196,000 |
| 7838216 |
Human gene related to but distinct from EGF receptor gene |
Matthias H. Kraus, Stuart A. Aaronson |
2010-11-23 |
|
| 7259142 |
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use |
Peter P. Roller, Ya-Qui Long, Feng-Di Lung, Dajun Yang, Johannes H. Voigt |
2007-08-21 |
|
| 7049409 |
Heregulin-like factor antibodies |
Paul Young, Mia Hijazi, Steven Ruben |
2006-05-23 |
$5,670,000 |
| 6951915 |
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use |
Peter P. Roller, Ya-Qiu Long, Feng-Di Lung, Dajun Yang |
2005-10-04 |
|
| 6727077 |
Heregulin-like factor |
Paul Young, Mai Hijazi, Steven Ruben |
2004-04-27 |
$16,088,000 |
| 6653084 |
Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor |
Matthias H. Kraus, Stuart A. Aaronson |
2003-11-25 |
|
| 6579522 |
Replication deficient adenoviral TNF vector |
Douglas E. Brough, Imre Kovesdi, Jasper J. Schaible |
2003-06-17 |
$1,900,000 |
| 6307090 |
Acylated oligopeptide derivatives having cell signal inhibiting activity |
Terrence R. Burke, Jr., Zhu-jun Yao |
2001-10-23 |
|
| 5985553 |
erbB-2 gene segments, probes, recombinant DNA and kits for detection |
Matthias H. Kraus, Stuart A. Aaronson |
1999-11-16 |
|
| 5747261 |
Protein related to but distinct from EGF receptor and antibodies reactive therewith |
Matthias H. Kraus, Stuart A. Aaronson |
1998-05-05 |
|
| 5587458 |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
Philip G. Kasprzyk, Robert E. Bird |
1996-12-24 |
$2,965,000 |